Tiziana Life Sciences
TLSA
3 hedge funds and large institutions have $2.87M invested in Tiziana Life Sciences in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.98% more ownership
Funds ownership: 0% → 1.98% (+2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$3.11M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$17.9K |
| 3 |
Tradewinds Capital Management
Bellingham,
Washington
|
+$146 |
Top Sellers
TLSA Hedge Fund Activity: Q4 2018 in Review
3 of the 4,506 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q4 2018, worth a combined $2.87M.
Buyers outnumbered sellers: 3 funds opened new TLSA positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was HighTower Advisors, opening a new position worth an estimated $3.11M.
- 3 institutional investors held Tiziana Life Sciences (TLSA) as of Q4 2018, up from 0 in Q3 2018.
- Funds reported $2.87M of Tiziana Life Sciences stock for Q4 2018.
- 3 funds opened new Tiziana Life Sciences positions in Q4 2018 and 0 closed out, a net change of +3 holders.
- The largest Tiziana Life Sciences buyer in Q4 2018 was HighTower Advisors, an estimated $3.11M added.
Based on aggregated 13F filings for Q4 2018.